CerraCap Ventures announces its investment in Somnoware, a
web-based platform transforming respiratory healthcare and
revolutionizing chronic care management.
COSTA
MESA, Calif., May 12, 2022
/PRNewswire/ -- CerraCap Ventures, an early-stage VC specializing
in cyber security, advanced analytics, and health-tech investments,
today announced its investment in Somnoware. This strategic
investment from CerraCap Ventures is poised to accelerate
Somnoware's expansion in sleep, respiratory care, and additional
healthcare markets.
Somnoware's mission is to reduce chronic respiratory disease
healthcare costs and improve patient outcomes by enabling early
diagnosis and more effective chronic care management.
Health care providers caring for patients with chronic
conditions such as sleep apnea and COPD struggle with the
collective problem of siloed data. Siloed data in disparate systems
creates barriers to patient care. Somnoware solves this problem
through a web-based platform for enhanced respiratory care
management. The platform orchestrates data flow between 100+
medical devices, unifies datasets within a single platform,
delivers high-impact analytics, enables faster diagnosis, proactive
intervention, & automated patient engagement.
By streamlining diagnostic testing workflows and driving greater
therapy adherence, Somnoware customers are improving treatment
outcomes. More than 1,500 diagnostic testing centers use
Somnoware.
Today, some of the largest healthcare systems in the US depend
on Somnoware to improve respiratory care management through
workflow automation, end-to-end care management, and population
risk analysis.
"With the goal of further solidifying its position as the
leading respiratory healthcare management platform, we are excited
about the future of the Somnoware platform to transform this space.
Their solution is well-designed for their end-users, and its
platform is experiencing major expansion. We are bullish about
their revenue traction and large iconic client base," said
Saurabh Ranjan, Founder & CEO of
CerraCap Ventures.
Subath Kamalasan, Founder and CEO
of Somnoware, said, "Healthcare systems realize now more than ever
that workflow automation and access to meaningful data is vital to
improving healthcare outcomes and reducing costs. This is why we
see increasing demand for a platform that enables healthcare
systems to integrate systems and devices, consolidate data, and
proactively engage with patients to improve care. This new
investment from CerraCap Ventures will accelerate Somnoware's
expansion into new markets and boost adoption of our platform by
healthcare systems nationwide."
CERRACAP VENTURES, is an Orange
County, California-based early-stage VC specializing in
cyber security, advanced analytics and health-tech investments that
predominantly focus on companies in B2B enterprise space. The firm
empowers high growth innovative companies by bringing sales from
Fortune 500 companies; they utilize their "Sales & Scale"
approach to industrialize innovation. www.cerracap.com
Somnoware is a cloud-based platform for enhanced respiratory
care management. The platform orchestrates data flow between
disparate medical devices, unifies datasets within a single
platform, and delivers high-impact analytics. The platform enables
screening, faster diagnosis, proactive intervention, and automated
patient engagement, resulting in improved treatment outcomes. Learn
more at somnoware.com.
For media inquiries, please contact:
Name: Nikki Arora
Email: na@cerracap.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cerracap-ventures-invests-in-somnoware-provider-of-platform-for-enhanced-respiratory-care-management-301545778.html
SOURCE CerraCap Ventures